Oi Harada

Obihiro, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence.

Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence.

Journal: Frontiers in oncology

Published: April 02, 2026

Artificial intelligence modelling in grading breast phyllodes tumours.

Artificial intelligence modelling in grading breast phyllodes tumours.

Journal: Histopathology

Published: December 05, 2025

Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.

Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.

Journal: Histopathology

Published: April 14, 2025

A Case of False-Negative Results in the One-Step Nucleic Acid Amplification Assay for Sentinel Lymph Node Metastasis in Breast Cancer with Low Cytokeratin 19 Expression.

A Case of False-Negative Results in the One-Step Nucleic Acid Amplification Assay for Sentinel Lymph Node Metastasis in Breast Cancer with Low Cytokeratin 19 Expression.

Journal: Case reports in oncology

Published: February 27, 2025

Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.

Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 15, 2024

Prognostic impact of tumor-associated neutrophils in breast cancer.

Prognostic impact of tumor-associated neutrophils in breast cancer.

Journal: International journal of clinical and experimental pathology

Published: December 22, 2023

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.

Journal: JCO precision oncology

Published: March 16, 2022

Substantial improvement of histopathological diagnosis by whole-slide image-based remote consultation.

Substantial improvement of histopathological diagnosis by whole-slide image-based remote consultation.

Journal: Virchows Archiv : an international journal of pathology

Published: November 06, 2021

Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.

Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 11, 2021

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast.

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast.

Journal: BMC cancer

Published: November 14, 2020

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer.

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: August 11, 2020

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.

Journal: BMC cancer

Published: October 18, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026